tradingkey.logo

STRATA Skin Sciences Inc

SSKN
1.175USD
+0.105+9.81%
交易中 美东报价延迟15分钟
71.28K总市值
亏损市盈率 TTM

STRATA Skin Sciences Inc

1.175
+0.105+9.81%

关于 STRATA Skin Sciences Inc 公司

STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

STRATA Skin Sciences Inc简介

公司代码SSKN
公司名称STRATA Skin Sciences Inc
上市日期Oct 28, 2005
CEORafaeli (Dolev)
员工数量106
证券类型Ordinary Share
年结日Oct 28
公司地址5 Walnut Grove Drive, Suite 140
城市HORSHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编19044
电话12156193200
网址https://www.strataskinsciences.com/
公司代码SSKN
上市日期Oct 28, 2005
CEORafaeli (Dolev)

STRATA Skin Sciences Inc公司高管

名称
名称/职务
职务
持股
持股变动
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
--
-32960.00%
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Mr. Shmuel (Samuel) Rubinstein
Mr. Shmuel (Samuel) Rubinstein
Independent Director
Independent Director
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-4675.00%
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
--
-32960.00%
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Mr. Shmuel (Samuel) Rubinstein
Mr. Shmuel (Samuel) Rubinstein
Independent Director
Independent Director
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-4675.00%
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States (Country)
5.22M
75.31%
Other foreign
939.00K
13.55%
Foreign
470.00K
6.78%
Middle East
172.00K
2.48%
China
130.00K
1.88%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 2月4日 周三
更新时间: 2月4日 周三
持股股东
股东类型
持股股东
持股股东
占比
Accelmed Growth Partners Management Ltd
24.49%
22NW, LP
9.12%
Nantahala Capital Management, LLC
6.86%
Lincoln Alternative Strategies LLC
6.21%
Renaissance Technologies LLC
1.72%
其他
51.60%
持股股东
持股股东
占比
Accelmed Growth Partners Management Ltd
24.49%
22NW, LP
9.12%
Nantahala Capital Management, LLC
6.86%
Lincoln Alternative Strategies LLC
6.21%
Renaissance Technologies LLC
1.72%
其他
51.60%
股东类型
持股股东
占比
Private Equity
24.49%
Investment Advisor/Hedge Fund
9.60%
Hedge Fund
8.62%
Corporation
6.21%
Investment Advisor
0.85%
Individual Investor
0.18%
其他
50.06%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
39
2.56M
43.55%
-107.46K
2025Q3
40
2.60M
49.33%
-171.52K
2025Q2
42
2.84M
68.01%
+22.22K
2025Q1
49
2.92M
70.24%
+3.78K
2024Q4
50
2.78M
66.72%
+102.20K
2024Q3
53
2.77M
66.42%
+227.70K
2024Q2
54
2.39M
67.77%
-279.08K
2024Q1
55
2.43M
68.82%
-232.89K
2023Q4
54
2.50M
71.18%
-175.24K
2023Q3
53
2.57M
73.29%
-212.86K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Accelmed Growth Partners Management Ltd
1.44M
24.49%
--
--
Sep 04, 2025
22NW, LP
537.00K
9.12%
--
--
Sep 30, 2025
Nantahala Capital Management, LLC
403.92K
6.86%
--
--
Sep 30, 2025
Lincoln Alternative Strategies LLC
365.85K
6.21%
+365.85K
--
Sep 03, 2025
Renaissance Technologies LLC
101.53K
1.72%
+3.50K
+3.57%
Sep 30, 2025
Geode Capital Management, L.L.C.
18.14K
0.31%
-56.00
-0.31%
Sep 30, 2025
The Vanguard Group, Inc.
23.55K
0.4%
-61.09K
-72.18%
Sep 30, 2025
Susquehanna International Group, LLP
12.43K
0.21%
+12.43K
--
Sep 30, 2025
Rubinstein (Samuel)
10.77K
0.18%
-9.09K
-45.79%
Nov 18, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
公告日期
除权除息日
类型
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
KeyAI